Table 1.
Variable | ΔCSI | Infarct size (%) | ||||||
---|---|---|---|---|---|---|---|---|
Treatment (number of ASCs) | MCAo (min) | Group size (n) | Data range | Median | IQR | Data range | Median | IQR |
Control | 45 | 8 | −0.032 to 0.087 | 0.047 | 0.078 | 0.7 to 15.8 | 6.96 | 9.25 |
90 | 9 | −0.143 to 0.156 | 0.055 | 0.066 | 1.1 to 17.2 | 3.23 | 6.76 | |
5 × 104 | 45 | 7 | 0.054 to 0.179 | 0.089 | 0.088 | 0.5 to 9.3 | 4.63 | 5.94 |
3 × 105 | 45 | 6 | 0.079 to 0.136 | 0.099 | 0.034 | 1.7 to 10 | 5.86 | 3.83 |
90 | 6 | 0.079 to 0.143 | 0.093 | 0.046 | 1.1 to 13.1 | 6.82 | 6.43 | |
1 × 106 | 45 | 4 | 0.014 to 0.2 | 0.157 | 0.12 | 3.8 to 26.1 | 13.37 | 16.93 |
90 | 3 | 0.083 to 0.379 | 0.12 | – | 4.2 to 20.6 | 19.64 | – |
ASC adipose tissue-derived stem cell, ΔCSI difference in cell signal intensity, IQR interquartile range, MCAo middle cerebral artery occlusion